对片冈直和、今村彻的回复。如何改善心动过速性心肌病患者的临床结局。对“卡茨等人。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412”的评论
Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412".
作者信息
Katz Moshe, Meitus Amit, Arad Michael, Aizer Anthony, Nof Eyal, Beinart Roy
机构信息
Sheba Medical Center, Ramat Gan 5266202, Israel.
School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
出版信息
J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.
Abstract
In a letter to the editor titled "How to improve clinical outcomes in patients with tachycardia-induced cardiomyopathy", Dr. Naoya Kataoka and Dr. Teruhiko Imamura [...].
摘要
在一封致编辑的题为《如何改善心动过速性心肌病患者的临床结局》的信中，片冈直也博士和今村辉彦博士[...]。
相似文献
1
Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412".对片冈直和、今村彻的回复。如何改善心动过速性心肌病患者的临床结局。对“卡茨等人。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412”的评论
J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.
2
How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412.如何改善心动过速性心肌病患者的临床结局。对卡茨等人的评论。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412。
J Clin Med. 2023 Aug 1;12(15):5065. doi: 10.3390/jcm12155065.
3
Importance of Comprehensive Assessment in Brugada Syndrome. Reply to Kataoka, N.; Imamura, T. How to Diagnose and Risk Stratify Brugada Syndrome. Comment on "Matusik et al. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. 2023, , 6581".布鲁加达综合征综合评估的重要性。对片冈直、今村智《如何诊断和进行布鲁加达综合征的风险分层》的回复。对“马图西克等人。布鲁加达综合征的十二导联心电图、动态心电图监测参数及基因检测：对有体力活动期间心脏骤停家族史的多代家族分析的见解。2023年，，6581”的评论
J Clin Med. 2024 Jan 31;13(3):811. doi: 10.3390/jcm13030811.
4
Reply to Weiss, H.-R. Comment on "Costa et al. The Effectiveness of Different Concepts of Bracing in Adolescent Idiopathic Scoliosis (AIS): A Systematic Review and Meta-Analysis. 2021, , 2145".回复魏斯，H.-R. 对《科斯塔等人。不同支具治疗青少年特发性脊柱侧凸（AIS）概念的有效性：系统评价和荟萃分析。2021年，，2145》的评论
J Clin Med. 2022 Feb 10;11(4):918. doi: 10.3390/jcm11040918.
5
Author's reply: Prognostic implication of exercise echocardiography in patients with hypertrophic cardiomyopathy, by Teruhiko Imamura.
J Cardiol. 2021 Jun;77(6):677-678. doi: 10.1016/j.jjcc.2021.02.001. Epub 2021 Feb 13.
6
Reply to Daitch et al. Comment on "Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Infection: A Meta-Analysis. 2022, , 3239".回复戴奇等人。对“黄等人。多粘菌素单药治疗与多粘菌素联合美罗培南治疗多重耐药感染的Meta分析。2022年，，3239”的评论。
J Clin Med. 2022 Dec 19;11(24):7508. doi: 10.3390/jcm11247508.
7
Reply to Eker et al. Comment on "Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. 2023, , 2704".对埃克等人的回复。关于“基利安等人。比较遗传性出血性毛细血管扩张症儿童和成人脑血管畸形的特征与治疗。2023年，，2704”的评论
J Clin Med. 2023 Dec 1;12(23):7462. doi: 10.3390/jcm12237462.
8
A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.一项评估胆钙化醇补充对桥本甲状腺炎自身免疫可能作用的前瞻性研究。
J Assoc Physicians India. 2023 Jan;71(1):1.
9
Reply to Chen et al. Improvements in Outcomes and Expanding Indications for the Commando Procedure. Comment on "Giambuzzi et al. Surgical Aortic Mitral Curtain Replacement: Systematic Review and Metanalysis of Early and Long-Term Results. 2021, , 3163".回复陈等人。突击手术的结果改善及适应证扩展。对“詹布齐等人。外科主动脉二尖瓣幕状置换术：早期和长期结果的系统评价与荟萃分析。2021年，，3163”的评论。
J Clin Med. 2022 Mar 14;11(6):1601. doi: 10.3390/jcm11061601.
10
Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women. 2022, , 1176".回复基尔布等人。女性患者的未开发潜力？评《卢卡等人。女性心血管疾病管理的最新进展。2022年，，1176》
J Clin Med. 2022 May 30;11(11):3086. doi: 10.3390/jcm11113086.
本文引用的文献
1
How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412.如何改善心动过速性心肌病患者的临床结局。对卡茨等人的评论。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412。
J Clin Med. 2023 Aug 1;12(15):5065. doi: 10.3390/jcm12155065.
2
Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy.与特发性扩张型心肌病相比，心动过速性心肌病的长期预后
J Clin Med. 2023 Feb 10;12(4):1412. doi: 10.3390/jcm12041412.
3
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
4
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.勘误：《2021欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗指南》：由欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组制定，并得到了ESC心力衰竭协会（HFA）的特别贡献。
Eur Heart J. 2021 Dec 21;42(48):4901. doi: 10.1093/eurheartj/ehab670.
5
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较：CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
6
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.心律失常性心肌病：美国心脏病学会最新综述
J Am Coll Cardiol. 2019 May 14;73(18):2328-2344. doi: 10.1016/j.jacc.2019.02.045.
7
Pathophysiology, diagnosis and treatment of tachycardiomyopathy.心动过速性心肌病的病理生理学、诊断与治疗
Heart. 2017 Oct;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391. Epub 2017 Aug 30.
8
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.特定扩张型心肌病的当前诊断和治疗策略：美国心脏协会的科学声明
Circulation. 2016 Dec 6;134(23):e579-e646. doi: 10.1161/CIR.0000000000000455. Epub 2016 Nov 3.
9
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].[2016年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南]
Kardiol Pol. 2016;74(10):1037-1147. doi: 10.5603/KP.2016.0141.
10
Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.特发性扩张型心肌病患者治疗策略的长期预后影响：过去 30 年死亡率的变化。
Eur J Heart Fail. 2014 Mar;16(3):317-24. doi: 10.1002/ejhf.16. Epub 2013 Dec 14.
Zotero 插件